Addex Therapeutics Ltd. (ADXN) Assets (2022 - 2024)

Addex Therapeutics' Assets history spans 3 years, with the latest figure at $12.2 million for Q4 2024.

  • For Q4 2024, Assets rose 132.93% year-over-year to $12.2 million; the TTM value through Dec 2024 reached $12.2 million, up 132.93%, while the annual FY2024 figure was $12.1 million, 134.85% up from the prior year.
  • Assets for Q4 2024 was $12.2 million at Addex Therapeutics, up from $5.2 million in the prior quarter.
  • Across five years, Assets topped out at $12.2 million in Q4 2024 and bottomed at $5.2 million in Q4 2023.
  • The 3-year median for Assets is $8.6 million (2022), against an average of $8.7 million.
  • The largest annual shift saw Assets tumbled 39.13% in 2023 before it skyrocketed 132.93% in 2024.
  • A 3-year view of Assets shows it stood at $8.6 million in 2022, then plummeted by 39.13% to $5.2 million in 2023, then surged by 132.93% to $12.2 million in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Assets are $12.2 million (Q4 2024), $5.2 million (Q4 2023), and $8.6 million (Q4 2022).